Apotex Inc. vs. Ipsen Biopharm Ltd. et al.
Explore the PTAB proceeding IPR2025-01531 filed by Apotex Inc. on 2025-09-12. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2025-01531
Filing Date
2025-09-12
Accorded Filing Date
2025-09-12
Institution Decision Date
2026-03-03
Last Modified Date
2026-10-20
Proceeding Type
IPR
Termination Date
2026-08-13
Trial Status
Final Written Decision
Parties & Counsel
Petitioner
Apotex Inc.
Represented By
Molenda, Johnet alPatent Owner / Respondent
Ipsen Biopharm Ltd. et al.
Represented By
Glass, Jameset alPatent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Decisions Rendered
2 Total
Proceeding Status
Final Written Decision
Administrative Patent Judges (APJ Panel)
Board Decisions & Rulings (2)
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 41195 | Arie Michelsohn | +1 240-792-2692 |
| 41551 | Lara Kelley | +1 703-243-2007 |
| 43076 | Fernando Salcedo | +1 919-620-2000 |
| 43796 | Rebecca Mcneill | +1 617-489-0002 |
| 46512 | Amy Schoenhard | +1 240-802-2716 |
| 47057 | Rebecca Scarr | +1 414-377-3455 |
| 48070 | Julie Heinrich | +1 412-744-3850 |
| 50775 | Heidi Dare | +1 872-270-2996 |
Global Patent Family Cross-Litigation Radar
CasLoc 360ยฐ Radar 12 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| ๐บ๐ธ United States | US 11,344,552 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2023006242 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2024035870 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2025038119 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2015622082 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2015622167 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2015622732 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2016622814 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2016623023 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2016623232 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2016623433 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2017004977 | US Continuation / Sibling | View Official Patent → |
CSPC Pharmaceutical Group Limited et al. v. Ipsen Biopharm Ltd. et al.